O'Brien P Q, Stevens L M, Hughes D C. "Method for the Synthesis of 3-(3-(Thiophen-2-yl)-1,2,4-oxadiazol-5-yl)-N-(o-tolyl)azetidine-1-carboxamide" [P]. US Patent, US 11285907 B2, 2020-07-21.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2014, 397, (11), 9300-9303.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2023, 376, 7307-7321.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 3-(3-(Thiophen-2-yl)-1,2,4-oxadiazol-5-yl)-N-(o-tolyl)azetidine-1-carboxamide Using HRMS and NMR". Anal. Chem., 2020, 1136, (3), 4032-4061.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2020, 2337, (7), 217-224.